News

Podcast

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Author(s):

Alexandra Gerlach, Associate Editor,Kevin Chen, PharmD

Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Warning sign surrounded by pills | Image Credit: © Vadym - stock.adobe.com
Network | Image Credit: © Georgy - stock.adobe.com
Medical team | Image Credit: © Jacob Lund - stock.adobe.com
Pharmacist inspecting medication. | Image Credit: © Inna - stock.adobe.com.
Related Content
Harnessing AI to Advance Clinical Trials and Oncology Pharmacy
August 4th 2025

Harnessing AI to Advance Clinical Trials and Oncology Pharmacy

Paul Alebrande, PharmD Candidate
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 4th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
AI-generated depiction of kidneys -- Image credit: arti om | stock.adobe.com
August 4th 2025

Study: Exposure to Trihalomethane Concentrations Increases CKD Risk

Gillian McGovern, Associate Editor
COBRRA Trial Results Raise Questions About VTE Management
August 4th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.
August 4th 2025

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Debra Patt, MD, PhD, MBA Jeff Hunnicutt
Concept of multiple myeloma cell | Image Credit: © LELISAT - stock.adobe.com
August 4th 2025

SAR446523 Granted Orphan Drug Designation for Patients With Relapsed, Refractory Multiple Myeloma

Alexandra Gerlach, Associate Editor